204 related articles for article (PubMed ID: 17413696)
1. Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women.
Richardson BA; Otieno PA; Mbori-Ngacha D; Overbaugh J; Farquhar C; John-Stewart GC
AIDS; 2007 Mar; 21(6):749-53. PubMed ID: 17413696
[TBL] [Abstract][Full Text] [Related]
2. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.
Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ
Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261
[TBL] [Abstract][Full Text] [Related]
3. Increased Cervical CD4
Lajoie J; Tjernlund A; Omollo K; Edfeldt G; Röhl M; Boily-Larouche G; Cheruiyot J; Kimani M; Kimani J; Oyugi J; Broliden K; Fowke KR
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing uptake of contraceptive implants in the immediate postpartum period among HIV infected and uninfected women at two Kenyan District Hospitals.
Shabiby MM; Karanja JG; Odawa F; Kosgei R; Kibore MW; Kiarie JN; Kinuthia J
BMC Womens Health; 2015 Aug; 15():62. PubMed ID: 26285582
[TBL] [Abstract][Full Text] [Related]
5. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
[TBL] [Abstract][Full Text] [Related]
6. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
Heffron R; Mugo N; Were E; Kiarie J; Bukusi EA; Mujugira A; Frenkel LM; Donnell D; Ronald A; Celum C; Baeten JM;
AIDS; 2014 Nov; 28(18):2771-6. PubMed ID: 25493602
[TBL] [Abstract][Full Text] [Related]
7. Mode of delivery and postpartum HIV-1 disease progression and mortality in a Kenyan cohort.
Unger JA; Richardson BA; Otieno PA; Farquhar C; Wamalwa D; John-Stewart GC
BMC Pregnancy Childbirth; 2014 Aug; 14():257. PubMed ID: 25086834
[TBL] [Abstract][Full Text] [Related]
8. Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe.
Bengtson A; Kwok C; Salata RA; Byamugisha J; Chipato T; Rwambuya S; Moyo P; Morrison CS
J Acquir Immune Defic Syndr; 2013 Aug; 63(4):506-13. PubMed ID: 23572011
[TBL] [Abstract][Full Text] [Related]
9. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
Thurman AR; Hammond N; Brown HE; Roddy ME
J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388
[TBL] [Abstract][Full Text] [Related]
10. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
11. Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.
Castilho JL; Jenkins CA; Shepherd BE; Bebawy SS; Turner M; Sterling TR; Melekhin VV
J Womens Health (Larchmt); 2015 Jun; 24(6):481-8. PubMed ID: 25751720
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.
Watts DH; Park JG; Cohn SE; Yu S; Hitti J; Stek A; Clax PA; Muderspach L; Lertora JJ
Contraception; 2008 Feb; 77(2):84-90. PubMed ID: 18226670
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Myer L; Denny L; Wright TC; Kuhn L
Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
[TBL] [Abstract][Full Text] [Related]
14. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.
Baeten JM; Benki S; Chohan V; Lavreys L; McClelland RS; Mandaliya K; Ndinya-Achola JO; Jaoko W; Overbaugh J
AIDS; 2007 Aug; 21(13):1771-7. PubMed ID: 17690576
[TBL] [Abstract][Full Text] [Related]
15. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
Jain AK
Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
[TBL] [Abstract][Full Text] [Related]
16. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.
Baeten JM; Nyange PM; Richardson BA; Lavreys L; Chohan B; Martin HL; Mandaliya K; Ndinya-Achola JO; Bwayo JJ; Kreiss JK
Am J Obstet Gynecol; 2001 Aug; 185(2):380-5. PubMed ID: 11518896
[TBL] [Abstract][Full Text] [Related]
17. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.
Morrison CS; Chen PL; Nankya I; Rinaldi A; Van Der Pol B; Ma YR; Chipato T; Mugerwa R; Dunbar M; Arts E; Salata RA
J Acquir Immune Defic Syndr; 2011 Jun; 57(2):157-64. PubMed ID: 21358412
[TBL] [Abstract][Full Text] [Related]
18. Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.
Weinberg A; Park JG; Bosch R; Cho A; Livingston E; Aweeka F; Cramer Y; Watts DH; Luque AE; Cohn SE
J Acquir Immune Defic Syndr; 2016 Feb; 71(2):137-45. PubMed ID: 26413850
[TBL] [Abstract][Full Text] [Related]
19. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
Nelson AL
J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
[TBL] [Abstract][Full Text] [Related]
20. High uptake of postpartum hormonal contraception among HIV-1-seropositive women in Kenya.
Balkus J; Bosire R; John-Stewart G; Mbori-Ngacha D; Schiff MA; Wamalwa D; Gichuhi C; Obimbo E; Wariua G; Farquhar C
Sex Transm Dis; 2007 Jan; 34(1):25-9. PubMed ID: 16691159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
